
Rachel Parker PhD FHEA
Programme Manager Industry Research Partnerships [Health]
- King's Innovation Catalyst
Biography
Talk to me
Contact me if you are a King’s researcher keen to discuss how partnering with industry may benefit your biomedical research, or if you are looking to find new industry partners to support, co-develop and co-deliver your research project(s).
About
Dr Rachel Parker bridges science, strategy, and stakeholder engagement to help King’s researchers advance their early-stage research through forging impactful pre-competitive collaborations and securing diversified research funding with external partners.
Rachel also leads on a number of long-term strategic research partnerships that King’s College London holds with companies, including Apollo Therapeutics, UCB and Unilever.
Rachel’s background is as a biomedical researcher, with a BSc (Hons) Biochemistry, University of Edinburgh a PhD in Neuroscience, University of Edinburgh and over 20 years of experience of basic, translational, and clinical research, spanning academia, national funding agencies, and the pharmaceutical sector.
News
King's and Apollo Therapeutics celebrate innovation partnership
Apollo Therapeutics and King's Research and Innovation staff celebrate drug discovery and development collaboration

News
King's and Apollo Therapeutics celebrate innovation partnership
Apollo Therapeutics and King's Research and Innovation staff celebrate drug discovery and development collaboration
